Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,148,085
+$954,840 QoQ
Shares Held
28,406
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,093
of 4,153 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2025CallValue
$111,372
CallShares
600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BTG Pactual Asset Management US LLC holds $22,218,069 across 4 Drug Manufacturers - General names. ABBV ranks #2 (32.2% of the industry book) .
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,148,085 | 28,406 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,193,245 | 28,476 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,227,394 | 22,878 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,478,699 | 23,662 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,897,593 | 10,223 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $111,372 | 600 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $2,061,257 | 9,838 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,386,593 | 7,803 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,633,554 | 8,272 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||